These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25808843)

  • 21. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
    Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
    Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases.
    Miranda E; Bianchi P; Destro A; Morenghi E; Malesci A; Santoro A; Laghi L; Roncalli M
    Cancer; 2013 Jan; 119(2):266-76. PubMed ID: 22786759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecularly annotation of mouse avatar models derived from patients with colorectal cancer liver metastasis.
    Wang J; Xing B; Liu W; Li J; Wang X; Li J; Yang J; Ji C; Li Z; Dong B; Gao J; Shen L
    Theranostics; 2019; 9(12):3485-3500. PubMed ID: 31281492
    [No Abstract]   [Full Text] [Related]  

  • 24. Single-cell DNA sequencing reveals a late-dissemination model in metastatic colorectal cancer.
    Leung ML; Davis A; Gao R; Casasent A; Wang Y; Sei E; Vilar E; Maru D; Kopetz S; Navin NE
    Genome Res; 2017 Aug; 27(8):1287-1299. PubMed ID: 28546418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of novel low passage primary and metastatic colorectal cancer cell lines.
    Boot A; van Eendenburg J; Crobach S; Ruano D; Speetjens F; Calame J; Oosting J; Morreau H; van Wezel T
    Oncotarget; 2016 Mar; 7(12):14499-509. PubMed ID: 26894854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosis.
    Bouchahda M; Karaboué A; Saffroy R; Innominato P; Gorden L; Guettier C; Adam R; Lévi F
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):605-9. PubMed ID: 20361188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KRAS mutation correlates with accelerated metastatic progression in patients with colorectal liver metastases.
    Nash GM; Gimbel M; Shia J; Nathanson DR; Ndubuisi MI; Zeng ZS; Kemeny N; Paty PB
    Ann Surg Oncol; 2010 Feb; 17(2):572-8. PubMed ID: 19727962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accurately identifying low-allelic fraction variants in single samples with next-generation sequencing: applications in tumor subclone resolution.
    Stead LF; Sutton KM; Taylor GR; Quirke P; Rabbitts P
    Hum Mutat; 2013 Oct; 34(10):1432-8. PubMed ID: 23766071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA copy number changes at 8q11-24 in metastasized colorectal cancer.
    Buffart TE; Coffa J; Hermsen MA; Carvalho B; van der Sijp JR; Ylstra B; Pals G; Schouten JP; Meijer GA
    Cell Oncol; 2005; 27(1):57-65. PubMed ID: 15750208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic changes in colorectal carcinoma tumors with liver metastases analyzed by comparative genomic hybridization and DNA ploidy.
    Nakao K; Shibusawa M; Ishihara A; Yoshizawa H; Tsunoda A; Kusano M; Kurose A; Makita T; Sasaki K
    Cancer; 2001 Feb; 91(4):721-6. PubMed ID: 11241239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity.
    Shi JY; Xing Q; Duan M; Wang ZC; Yang LX; Zhao YJ; Wang XY; Liu Y; Deng M; Ding ZB; Ke AW; Zhou J; Fan J; Cao Y; Wang J; Xi R; Gao Q
    Oncotarget; 2016 Jan; 7(3):2867-77. PubMed ID: 26672766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular markers for colorectal cancer liver metastases: initial results and perspectives].
    Oudet P; Schneider A; Neuville A; Weber JC; Rohr S
    Bull Acad Natl Med; 2003; 187(5):847-60; discussion 861. PubMed ID: 14979051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A system for detecting high impact-low frequency mutations in primary tumors and metastases.
    Anjanappa M; Hao Y; Simpson ER; Bhat-Nakshatri P; Nelson JB; Tersey SA; Mirmira RG; Cohen-Gadol AA; Saadatzadeh MR; Li L; Fang F; Nephew KP; Miller KD; Liu Y; Nakshatri H
    Oncogene; 2018 Jan; 37(2):185-196. PubMed ID: 28892047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers.
    Li X; Kumar S; Harmanci A; Li S; Kitchen RR; Zhang Y; Wali VB; Reddy SM; Woodward WA; Reuben JM; Rozowsky J; Hatzis C; Ueno NT; Krishnamurthy S; Pusztai L; Gerstein M
    Genome Med; 2021 Apr; 13(1):70. PubMed ID: 33902690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of chromosomal aberrations of metastatic potential in colorectal carcinoma.
    Yamamoto S; Midorikawa Y; Morikawa T; Nishimura Y; Sakamoto H; Ishikawa S; Akagi K; Aburatani H
    Genes Chromosomes Cancer; 2010 May; 49(5):487-96. PubMed ID: 20175194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of colorectal cancer by comparative genomic hybridization: evidence for induction of the metastatic phenotype by loss of tumor suppressor genes.
    Paredes-Zaglul A; Kang JJ; Essig YP; Mao W; Irby R; Wloch M; Yeatman TJ
    Clin Cancer Res; 1998 Apr; 4(4):879-86. PubMed ID: 9563881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of allelic imbalance in patients with colorectal cancer according to stage and presence of synchronous liver metastases.
    Weber JC; Schneider A; Rohr S; Nakano H; Bachellier P; Méchine A; Hamel G; Kanor M; Chenard MP; Gaub MP; Oudet P; Meyer C; Jaeck D
    Ann Surg; 2001 Dec; 234(6):795-802; discussion 802-3. PubMed ID: 11729386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain.
    Stange DE; Engel F; Longerich T; Koo BK; Koch M; Delhomme N; Aigner M; Toedt G; Schirmacher P; Lichter P; Weitz J; Radlwimmer B
    Gut; 2010 Sep; 59(9):1236-44. PubMed ID: 20479215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression differences in primary colorectal tumors and matched liver metastases: chemotherapy related or tumoral heterogeneity?
    López-Gómez M; Moreno-Rubio J; Suárez-García I; Cejas P; Madero R; Casado E; Jiménez AM; Sereno M; Gómez-Raposo C; Zambrana F; Merino M; Fernández-Luengas D; Feliu J
    Clin Transl Oncol; 2015 Apr; 17(4):322-9. PubMed ID: 25301403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The status of EGFR-associated genes could predict the outcome and tumor response of chemo-refractory metastatic colorectal patients using cetuximab and chemotherapy.
    Lin JK; Lin AJ; Lin CC; Lan YT; Yang SH; Li AF; Chang SC
    J Surg Oncol; 2011 Nov; 104(6):661-6. PubMed ID: 21671463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.